Vimarsana
Biggest News Aggregation in the World

Page 8 - Tim Crew News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tim Crew. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tim Crew Today - Breaking & Trending Today

LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS - Vimarsana News

LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 third quarter ended March 31, 2022....

LANNETT INITIATES PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINE - Vimarsana News

LANNETT INITIATES PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINE

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has initiated the pivotal clinical trial of biosimilar insulin glargine, a product...

LANNETT Announces sale of liquid drug manufacturing plant and other assets for $10.5 million - Vimarsana News

LANNETT Announces sale of liquid drug manufacturing plant and other assets for $10.5 million

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into material definitive agreements to sell its liquid drug manufacturing...

LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE - Vimarsana News

LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 second quarter ended December 31, 2021. "For the...

LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE - Vimarsana News

LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 second quarter ended December 31, 2021. "For the...